Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO-Reference-Cited by-同舟云学术

Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO

Published:2007-03-29 Issue:2 Volume:61 Page:243-250
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Sehouli Jalid,Stengel Dirk,Mustea Alexander,Camara Oumar,Keil Elke,Elling Dirk,Ledwon Peter,Christiansen Bernd,Klare Peter,Gebauer Gerhard,Schwarz Marina,Lichtenegger Werner,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0466-z.pdf

Reference34 articles.

1. Bookman MA for the Gynecologic Cancer InterGroup (GCIG) through the Gynecologic Oncology Group (GOG) (2006) GOG0182-ICON5: 5-arm phase III randomized trial of paclitaxel and carboplatin vs combinations with gemcitabine, PEG-lipososomal doxorubicin, or topotecan in patients with advanced-stage epithelial ovarian or primary peritoneal carcinoma (Abstract 5002). J Clin Oncol 24 (Suppl 18):256s

2. Advanced Ovarian Cancer Trialists Group. Chemotherapy for advanced ovarian cancer (1999) Cochrane Database of Systematic Reviews 1999, Issue 1. Art. No.: CD001418. doi: 10.1002/14651858.CD001418

3. Rosenberg P, Andersson H, Boman K, Ridderheim M, Sorbe B, Puistola U, Paro G (2002) Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum. Acta Oncol 41:418–424

4. Berek JS, Bertelsen K, du Bois A et al (1999) Advanced epithelial ovarian cancer: 1998 consensus statement. Ann Oncol 10(Suppl 1):87–92

5. National Comprehensive Cancer Network (2006) Clinical Practice Guidelines in Oncology-v.1.2006. Ovarian Cancer. Available at http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of weekly paclitaxel for the treatment of advanced ovarian cancer;Medicine;2020-06-19

2. First-Line Management of Advanced High-Grade Serous Ovarian Cancer;Current Oncology Reports;2020-06

3. Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status;International Journal of Clinical Oncology;2018-03-23

4. Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer;Gynecologic Oncology;2017-10

5. A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma;Journal of Cancer;2017